These drugs, used to treat type 2 diabetes and obesity, are particularly vulnerable to contamination because of their complex structure and manufacturing processes, reports Bryan Tackett, Product Marketing Manager Brand & Global Communications, Phenomenex.
The presence of foreign matter can greatly affect their therapeutic performance, making impurity profiling a crucial element of drug development and production.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.